Methodological considerations in prognostic modeling for HER2-positive breast cancer with lung metastasis. Altundag O, Altundag K. Breast Cancer 2026 Jun 16. doi: 10.1007/s12282-026-01885.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Altundag O, Altundag K. Methodological considerations in prognostic modeling for HER2-positive breast cancer with lung metastasis. Breast Cancer 2026 Jun 16. doi: 10.1007/s12282-026-01885.
PMID: 42301384